Multiparameter flow cytometry and bioanalytics for B cell profiling in systemic lupus erythematosus

Methods in Molecular Biology

Volumn 900, Issue , 2012, Pages 109-134

  Kaminski, Denise A ^a   Wei, Chungwen ^a   Rosenberg, Alexander F ^a   Lee, F Eun Hung ^a   Sanz, Ignacio ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

9G4; Antibody secreting cell; Autoantibody; B cell subset; B lymphocyte; Mature na ve B cell; Memory B cell; Principal component analysis; Systemic lupus erythematosus; Transitional B cell

Indexed keywords

EID: 84868534129     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-720-4_6     Document Type: Article

References (95)

1. Pons-Estel GJ et al (2008) Understanding the epidemiology and progression of systemic lupus erythematosis. Semin Arthritis Rheum 39: 257-2688
2. Borchers AT et al (2010) The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 9:A277-A2877
3. Bertsias GK, Salmon JE, Boumpas DT (2010) Therapeutic opportunities in systemic lupus erythematosus: State of the art and prospects for the new decade. Ann Rheum Dis 69:1603-16111
4. Arbuckle MR et al (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349: 1526-15333
5. Anolik JH et al (2009) Insights into the heterogeneity of human B cells: Diverse functions, roles in autoimmunity, and use as therapeutic targets. Immunol Res (2009) 45:144-1588
6. Wardemann H et al (2003) Predominant autoantibody production by early human B cell precursors. Science 301:1374-13777
7. Yurasov S et al (2005) Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med 201:703-7111
8. Yurasov S et al (2006) Persistent expression of autoantibodies in SLE patients in remission. J Exp Med 203:2255-22611
9. Yurasov S et al (2005) B-cell tolerance checkpoints in healthy humans and patients with systemic lupus erythematosus. Ann N Y Acad Sci 1062:165-1744
10. Yurasov S, Nussenzweig MC (2007) Regulation of autoreactive antibodies. Curr Opin Rheumatol 19:421-4266
11. Tiller T et al (2007) Autoreactivity in human IgG+ memory B cells. Immunity 26:205-2133
12. Sherer Y et al (2004) Autoantibody explosion in systemic lupus erythematosus: More than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 34:501-5377
13. Huang W et al (2002) The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus. Arthritis Rheum 46: 1554-15622
14. Erdei A et al (2009) Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions. Mol Immunol 46:2767-27733
15. Casciola-Rosen LA, Anhalt G, Rosen A (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179:1317-13300
16. Schutters K, Reutelingsperger C (2010) Phosphatidylserine targeting for diagnosis and treatment of human diseases. Apoptosis 15: 1072-10822
17. Pugh-Bernard AE et al (2001) Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J Clin Invest 108:1061-10700
18. Isenberg D et al (1993) Identi fi cation of the 9G4 idiotope in systemic lupus erythematosus. Br J Rheumatol 32:876-8822
19. van Vollenhoven RF et al (1999) VH4-34 encoded antibodies in systemic lupus erythematosus: A speci fi c diagnostic marker that correlates with clinical disease characteristics. J Rheumatol 26:1727-17333
20. Bhat NM et al (2002) VH4-34 encoded antibody in systemic lupus erythematosus: Effect of isotype. J Rheumatol 29:2114-21211
21. Sanz I, Lee FE (2010) B cells as therapeutic targets in SLE. Nat Rev Rheumatol 6:326-3377
22. Anolik JH et al (2004) Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. Arthritis Rheum 50:3580-35900
23. Calero I, Sanz I (2010) Targeting B cells for the treatment of SLE: The beginning of the end or the end of the beginning? Discov Med 10: 416-4244
24. Shlomchik MJ et al (1994) The role of B cells in lpr/lpr-induced autoimmunity. J Exp Med 180:1295-13066
25. Chan OT et al (1999) A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 189:1639-16488
26. Ahuja A et al (2007) Depletion of B cells in murine lupus: Ef fi cacy and resistance. J Immunol 179:3351-33611
27. Looney RJ et al (2004) B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose-escalation trial of rituximab. Arthritis Rheum 50:2580-25899
28. Navarra SV et al (2001) Ef fi cacy and safety of belimumab in patients with active systemic lupus erythematosus: A randomised, placebocontrolled, phase 3 trial. Lancet 377:721-7311
29. Chan O, Shlomchik MJ (1998) A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRLlpr/lpr mice. J Immunol 160:51-599
30. Anolik JH et al (2007) Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy. Arthritis Rheum 56:3044-30566
31. Sanz I et al (2008) Phenotypic and functional heterogeneity of human memory B cells. Semin Immunol 20:67-822
32. Wehr C et al (2004) A new CD21low B cell population in the peripheral blood of patients with SLE. Clin Immunol 113:161-1711
33. Odendahl M et al (2000) Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol 165:5970-59799
34. Wirths S, Lanzavecchia A (2005) ABCB1 transporter discriminates human resting naive B cells from cycling transitional and memory B cells. Eur J Immunol 35:3433-34411
35. Palanichamy A et al (2009) Novel human transitional B cell populations revealed by B cell depletion therapy. J Immunol 182:5982-59933
36. Pascual V et al (1994) Analysis of somatic mutation in fi ve B cell subsets of human tonsil. J Exp Med 180:329-3399
37. Wellmann U et al (2005) The evolution of human anti-double-stranded DNA autoantibodies. Proc Natl Acad Sci USA 102:9258-92633
38. Tsuiji M et al (2006) A checkpoint for autoreactivity in human IgM+ memory B cell development. J Exp Med 203:393-4000
39. Cappione A 3rd et al (2005) Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J Clin Invest 115:3205-32166
40. Vinuesa CG, Sanz I, Cook MC (2009) Dysregulation of germinal centres in autoimmune disease. Nat Rev Immunol 9:845-8577
41. Crotty S, Ahmed R (2004) Immunological memory in humans. Semin Immunol 16:197-2033
42. Mamani-Matsuda M et al (2008) The human spleen is a major reservoir for long-lived vaccinia virus-speci fi c memory B cells. Blood 111: 4653-46599
43. Anderson SM, Tomayko MM, Shlomchik MJ (2006) Intrinsic properties of human and murine memory B cells. Immunol Rev 211: 280-2944
44. Agematsu K et al (1997) B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production. Eur J Immunol 27: 2073-20799
45. Tangye SG et al (2003) Intrinsic differences in the proliferation of naive and memory human B cells as a mechanism for enhanced secondary immune responses. J Immunol 170:686-6944
46. Good KL, Avery DT, Tangye SG (2009) Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells. J Immunol 182:890-9011
47. Tangye SG, Avery DT, Hodgkin PD (2003) A division-linked mechanism for the rapid generation of Ig-secreting cells from human memory B cells. J Immunol 170:261-2699
48. Macallan DC et al (2005) B-cell kinetics in humans: Rapid turnover of peripheral blood memory cells. Blood 105:3633-36400
49. van Gent R et al (2009) Re fi ned characterization and reference values of the pediatric T- and B-cell compartments. Clin Immunol 133:95-1077
50. Kruetzmann S et al (2003) Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med 197:939-9455
51. Grif fi n DO, Holodick NE, Rothstein TL (2011) Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70-RDDDDD. J Exp Med 208:67-800
52. Wei C et al (2007) A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J Immunol 178:6624-66333
53. Fecteau JF, Cote G, Neron S (2006) A new memory CD27-IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation. J Immunol 177:3728-37366
54. Klein U, Rajewsky K, Kuppers R (1998) Human immunoglobulin (Ig)M+ IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 188:1679-16899
55. Qian Y et al (2010) Elucidation of seventeen human peripheral blood B-cell subsets and quanti fi cation of the tetanus response using a density-based method for the automated identi fi cation of cell populations in multidimensional fl ow cytometry data. Cytometry B Clin Cytom 78(Suppl 1):S69-S822
56. Dunn-Walters DK, Isaacson PG, Spencer J (1995) Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells. J Exp Med 182:559-5666
57. Weller S et al (2008) Somatic diversi fi cation in the absence of antigen-driven responses is the hallmark of the IgM+ IgD+ CD27+ B cell repertoire in infants. J Exp Med 205:1331-13422
58. Wu YC et al (2010) High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations. Blood 116:1070-10788
59. Seifert M, Kuppers R (2009) Molecular footprints of a germinal center derivation of human IgM+(IgD+)CD27+ B cells and the dynamics of memory B cell generation. J Exp Med 206: 2659-26699
60. Wasserstrom H et al (2008) Memory B cells and pneumococcal antibody after splenectomy. J Immunol 181:3684-36899
61. Iwata Y et al (2011) Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 117:530-5411
62. Dogan I et al (2009) Multiple layers of B cell memory with different effector functions. Nat Immunol 10:1292-12999
63. Pape KA et al (2011) Different B cell populations mediate early and late memory during an endogenous immune response. Science 331: 1203-12077
64. Weller S et al (2001) CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversi fi cation pathway in humans. Proc Natl Acad Sci USA 98:1166-11700
65. Mietzner B et al (2008) Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors. Proc Natl Acad Sci USA 105:9727-97322
66. Snapper CM, Mond JJ (1993) Towards a comprehensive view of immunoglobulin class switching. Immunol Today 14:15-177
67. Rodriguez-Bayona B et al (2010) Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients. Arthritis Res Ther 12:R1088
68. Korganow AS et al (2010) Peripheral B cell abnormalities in patients with systemic lupus erythematosus in quiescent phase: Decreased memory B cells and membrane CD19 expression. J Autoimmun 34:426-4344
69. Houtkamp MA et al (2001) Adventitial in fi ltrates associated with advanced atherosclerotic plaques: Structural organization suggests generation of local humoral immune responses. J Pathol 193:263-2699
70. Kyaw T et al (2010) Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J Immunol 185:4410-44199
71. Sjoberg BG et al (2009) Low levels of IgM antibodies against phosphorylcholine-A potential risk marker for ischemic stroke in men. Atherosclerosis 203:528-5322
72. Zhou X, Hansson GK (1999) Detection of B cells and proin fl ammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice. Scand J Immunol 50:25-300
73. Ait-Oufella H et al (2010) B cell depletion reduces the development of atherosclerosis in mice. J Exp Med 207:1579-15877
74. Halliley JL et al (2010) Peak frequencies of circulating human in fl uenza-speci fi c antibody secreting cells correlate with serum antibody response after immunization. Vaccine 28: 3582-35877
75. Gonzalez-Garcia I et al (2006) Immunizationinduced perturbation of human blood plasma cell pool: Progressive maturation, IL-6 responsiveness, and high PRDI-BF1/BLIMP1 expression are critical distinctions between antigen-speci fi c and nonspeci fi c plasma cells. J Immunol 176:4042-40500
76. Odendahl M et al (2005) Generation of migratory antigen-speci fi c plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood 105:1614-16211
77. Lee FE et al (2010) Circulating antibodysecreting cells during acute respiratory syncytial virus infection in adults. J Infect Dis 202: 1659-16666
78. Fairfax KA et al (2008) Plasma cell development: From B-cell subsets to long-term survival niches. Semin Immunol 20:49-588
79. Oracki SA et al (2010) Plasma cell development and survival. Immunol Rev 237:140-1599
80. Caraux A et al (2010) Circulating human B and plasma cells. Age-Associated changes in counts and detailed characterization of circulating normal CD138- and CD138+ plasma cells. Haematologica 95:1016-10200
81. Bernasconi NL, Traggiai E, Lanzavecchia A (2002) Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298:2199-22022
82. Jacobi AM et al (2010) Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: Extension of a phase II, double-blind, placebo-controlled, dose-ranging study. Arthritis Rheum 62:201-2100
83. Moir S et al (2008) Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease. J Infect Dis 197:572-5799
84. Jacobi AM et al (2008) Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: Delineation by expression of CD27, IgD, and CD95. Arthritis Rheum 58:1762-17733
85. Habib LK, Finn WG (2006) Unsupervised immunophenotypic pro fi ling of chronic lymphocytic leukemia. Cytometry B Clin Cytom 70:124-1355
86. Diaz-Romero J et al (2010) Hierarchical clustering of fl ow cytometry data for the study of conventional central chondrosarcoma. J Cell Physiol 225:601-6111
87. Cappione AJ et al (2004) Lupus IgG VH4.34 antibodies bind to a 220-kDa glycoform of CD45/B220 on the surface of human B lymphocytes. J Immunol 172:4298-43077
88. Herzenberg LA et al (2006) Interpreting fl ow cytometry data: A guide for the perplexed. Nat Immunol 7:681-6855
89. Eisen MB et al (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-148688
90. D'haeseleer (2005) How does gene expression clustering work? Nat Biotechnol 23: 1499-15011
91. Quackenbush J (2001) Computational analysis of microarray data. Nat Rev Genet 2: 418-4277
92. Misra J et al (2002) Interactive exploration of microarray gene expression patterns in a reduced dimensional space. Genome Res 12: 1112-11200
93. Lugli E et al (2007) Subject classi fi cation obtained by cluster analysis and principal component analysis applied to fl ow cytometric data. Cytometry A 71:334-3444
94. Lee FE et al (2011) Circulating human antibody-secreting cells during vaccinations and respiratory viral infections are characterized by high speci fi city and lack of bystander effect. J Immunol 186:5514-55211
95. Wei et al (2011) OMIP-003: Phenotypic analysis of human memory B cells. Cytometry A 79:894-8966